Calcitriol (1,25-dihydroxylcholecaldiferol,32222-06-3) is a steroid hormone with three hydroxyl groups, which is an active metabolite and the most effective form of vitamin D. It is produced primarily in the kidney when the blood calcium level and parathyroid hormone are low. Calcitriol promotes the calcium and phosphorus absorption in the intestine, reabsorption in the kidneys. Along with parathyroid hormone, it regulates bone growth for building and keeping strong bones. Calcitriol is used to treat and prevent low levels of calcium and bone disease in patients whose kidneys or parathyroid glands are not working normally, to treat secondary hyperparathyroidism and metabolic bone disease in people with kidney disease. Calcitriol may also be chemopreventive for colon and prostate cancers as it induces cell cycle arrest, cell differentiation, and apoptosis.
- https://pubchem.ncbi.nlm.nih.gov
- https://medlineplus.gov
- http://flexikon.doccheck.com/en/Calcitriol
- https://en.wikipedia.org/wiki/Calcitriol
- https://www.webmd.com
Calcitriol is the active form of vitamin D and is also a kind of hormones in the body. It plays an important role in the regulation of calcium and phosphorus concentration. It can increase the blood calcium level by increasing the intestinal absorption of calcium and can also increase the release of the bone calcium release for increasing the blood calcium levels. Plasma levels of calcitriol range from 10-70 pg/ml. Clinically, this drug can be used in the treatment of hypocalcemia, hypoparathyroidism (adult), osteomalacia, rickets (infants), chronic kidney disease, renal osteodystrophy, osteoporosis, as well as the prevention of glucocorticoid induced osteoporosis.
Calcitriol-dimensional molecular structure
The above information is edited by the chemicalbook of Dai Xiongfeng.
Calcitriol is the biologically active form of vitamin D3, and its primary physiological effects are to increase calcium absorption by intestinal epithelial cells and increase bone mineralization by directly stimulating osteoblasts. It is therefore also used as a calcium regulator to treat symptoms of low calcium levels caused by kidney disease. It can also treat parathyroid disease. Calcitriol can regulate parathyroid levels by increasing the amount of calcium (vitamin D) in the body.
ChEBI: Calcitriol is a hydroxycalciol that is calcidiol in which the pro-S hydrogen of calcidiol is replaced by a hydroxy group. It is the active form of vitamin D3, produced fom calciol via hydoxylation in the liver to form calcidiol, which is subsequently oxidised in the kidney to give calcitriol. It has a role as a bone density conservation agent, an antipsoriatic, an immunomodulator, an antineoplastic agent, a calcium channel modulator, a nutraceutical, a calcium channel agonist, a metabolite, a hormone, a human metabolite and a mouse metabolite. It is a hydroxycalciol, a member of D3 vitamins and a triol.
1α,25-Dihydroxyprecholecalciferol: A solution of 1α,25-
diacetoxyprecholecalciferol (0.712 g, 1.42 mmols), potassium hydroxide (2.0
g, 35.6 mmols) and methanol (40 ml) was stirred at room temperature under
argon for 30 hours. The reaction mixture was concentrated under reduced
pressure. Water (50 ml) was added to the residue and the mixture was
extracted with methylene chloride (3 x 100 ml). The combined organic
extracts were washed with saturated sodium chloride solution (3 x 50 ml),
dried over anhydrous sodium sulfate, filtered and evaporated under reduced
pressure to give 0.619 g of 1alpha,25-dihydroxyprecholecalciferol as a thick
oil.
1α,25-Dihydroxycholecalciferol: A solution of 1α,25-dihydroxyprecholecalciferol
[0.619 g in dioxane (30 ml)] was heated under reflux for 30 minutes under an
atmosphere of argon. The reaction mixture was concentrated under reduced pressure and the residue was purified with a Waters Associates liquid
chromatograph model 202 using a 8 foot * 3/8 inch Porasil A column and a
5:1 mixture of ethyl acetate-n-hexane as the eluent to give 0.474 g (80%
yield based on 1α,25-diacetoxyprecholecalciferol) of pure 1α,25-
dihydroxycholecalciferol. Recrystallization from methyl formate afforded 0.340
g of 1α,25-dihydroxcholecalciferol as colorless crystals, MP 113°-114°C.
Calcijex (Abbott); Rocaltrol (Roche.
1α,25-Dihydroxyvitamin D3, also referred as calcitriol, is a calcitrophic hormone. It is the most biologically active metabolite of vitamin D produced in proximal tubular cells in the kidney.
Active metabolite of vitamin D 3 that activates the vitamin D receptor (VDR). Displays calcemic actions; stimulates intestinal and renal Ca 2+ absorption and regulates bone Ca 2+ turnover. Exhibits antitumor activity; inhibits in vivo and in vitro cell proliferation in a wide range of cells including breast, prostate, colon, skin and brain carcinomas and myeloid leukemia cells.
Biologically active form of vitamin D3 in calcium absorption and deposition. 1α,25-Dihydroxyvitamin D3 has widespread effects on cellular differentiation and proliferation, and can modulate immune responsiveness, and central nervous system function. Recent studies suggest that 1α,25-dihydroxyvitamin D3 acts as a chemopreventive agent against several malignancies including cancers of the prostate and colon and shows synergy with other anticancer compounds.
Vitamin D analogue:
Promotes intestinal calcium absorption
Suppresses PTH production and release
Veterinary Drugs and Treatments
Calcitriol may be potentially beneficial in the adjunctive treatment
of chronic renal
disease in dogs and cats but its use is somewhat
controversial, particularly the decision on how soon in the course
of chronic renal insufficiency it should employed. It may also be of
benefit in treating some types of dermatopathies (primary idiopathic
seborrhea).
Potentially hazardous interactions with other drugs
Antiepileptics: the effects of vitamin D may
be reduced in patients taking barbiturates or
anticonvulsants.
Diuretics: increased risk of hypercalcaemia with
thiazides.
Sevelamer: absorption may be impaired by sevelamer
During transport in the blood at physiological
concentrations, calcitriol is mostly bound to a specific
vitamin D binding protein (DBP), but also, to a lesser
degree, to lipoproteins and albumin. At higher blood
calcitriol concentrations, DBP appears to become
saturated, and increased binding to lipoproteins and
albumin occurs.
Calcitriol is inactivated in both the kidney and
the intestine, through the formation of a number
of intermediates including the formation of the
1,24,25-trihydroxy derivatives. It is excreted in the bile
and faeces and is subject to enterohepatic circulation.
